STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
ViroMissile, Inc.
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
University of Washington
Day One Biopharmaceuticals, Inc.
Jonsson Comprehensive Cancer Center
University of Pittsburgh
Nuvation Bio Inc.
Cancer Research UK
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Centre Georges Francois Leclerc
National Cancer Institute (NCI)
Purple Biotech Ltd.
Rain Oncology Inc
Peking University
Yonsei University
Catholic University of the Sacred Heart
Stanford University
Charite University, Berlin, Germany
Georgetown University
Hoffmann-La Roche
Tianjin Medical University Cancer Institute and Hospital
Provectus Pharmaceuticals
Laser Tissue Welding, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Grupo Espanol de Tumores Neuroendocrinos
Pfizer
Masonic Cancer Center, University of Minnesota
Novartis
Columbia University
Assistance Publique - Hôpitaux de Paris
Istituto Clinico Humanitas
INSYS Therapeutics Inc
Delcath Systems Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
Mannkind Corporation
Federico II University